Chen F - Search Results

1

Bispecific prodrug nanoparticles circumventing multiple immune resistance mechanisms for promoting cancer immunotherapy.

Ye J, Hou B, Chen F, Zhang S, Xiong M, Li T, Xu Y, Xu Z, Yu H. Ye J, et al. Among authors: chen f. Acta Pharm Sin B. 2022 Jun;12(6):2695-2709. doi: 10.1016/j.apsb.2021.09.021. Epub 2021 Sep 25. Acta Pharm Sin B. 2022. PMID: 35755274 Free PMC article.

2

Nanobiomaterial-based vaccination immunotherapy of cancer.

Chen F, Wang Y, Gao J, Saeed M, Li T, Wang W, Yu H. Chen F, et al. Biomaterials. 2021 Mar;270:120709. doi: 10.1016/j.biomaterials.2021.120709. Epub 2021 Feb 5. Biomaterials. 2021. PMID: 33581608 Review.

3

Stimuli-activatable nanomaterials for phototherapy of cancer.

Zhou M, Liu X, Chen F, Yang L, Yuan M, Fu DY, Wang W, Yu H. Zhou M, et al. Among authors: chen f. Biomed Mater. 2021 May 10;16(4). doi: 10.1088/1748-605X/abfa6e. Biomed Mater. 2021. PMID: 33882463 Review.

4

Engineering Nanorobots for Tumor-Targeting Drug Delivery: From Dynamic Control to Stimuli-Responsive Strategy.

Huang L, Chen F, Lai Y, Xu Z, Yu H. Huang L, et al. Among authors: chen f. Chembiochem. 2021 Dec 10;22(24):3369-3380. doi: 10.1002/cbic.202100347. Epub 2021 Sep 14. Chembiochem. 2021. PMID: 34411411 Review.

5

Stimuli-Sheddable Nanomedicine Overcoming Pathophysiological Barriers for Potentiating Immunotherapy of Cancer.

Wang J, Zhou M, Chen F, Liu X, Gao J, Wang W, Wang H, Yu H. Wang J, et al. Among authors: chen f. J Biomed Nanotechnol. 2021 Aug 1;17(8):1486-1509. doi: 10.1166/jbn.2021.3134. J Biomed Nanotechnol. 2021. PMID: 34544528

6

Engineered nanomedicines block the PD-1/PD-L1 axis for potentiated cancer immunotherapy.

Li JH, Huang LJ, Zhou HL, Shan YM, Chen FM, Lehto VP, Xu WJ, Luo LQ, Yu HJ. Li JH, et al. Acta Pharmacol Sin. 2022 Nov;43(11):2749-2758. doi: 10.1038/s41401-022-00910-w. Epub 2022 Apr 28. Acta Pharmacol Sin. 2022. PMID: 35484402 Free PMC article. Review.

7

Sequentially Activatable Polypeptide Nanoparticles for Combinatory Photodynamic Chemotherapy of Breast Cancer.

Zhang H, Pan J, Wang T, Lai Y, Liu X, Chen F, Xu L, Qu X, Hu X, Yu H. Zhang H, et al. Among authors: chen f. ACS Appl Mater Interfaces. 2022 Sep 7;14(35):39787-39798. doi: 10.1021/acsami.2c09064. Epub 2022 Aug 24. ACS Appl Mater Interfaces. 2022. PMID: 36001127

8

Dual-targeting prodrug nanotheranostics for NIR-Ⅱ fluorescence imaging-guided photo-immunotherapy of glioblastoma.

Li F, Lai Y, Ye J, Saeed M, Dang Y, Zou Z, Chen F, Zhang W, Xu Z. Li F, et al. Among authors: chen f. Acta Pharm Sin B. 2022 Sep;12(9):3486-3497. doi: 10.1016/j.apsb.2022.05.016. Epub 2022 May 20. Acta Pharm Sin B. 2022. PMID: 36176914 Free PMC article.

9

Self-Cooperative Prodrug Nanovesicles Migrate Immune Evasion to Potentiate Chemoradiotherapy in Head and Neck Cancer.

Zhu Y, Zhang S, Lai Y, Pan J, Chen F, Wang T, Wang F, Xu Z, Yang W, Yu H. Zhu Y, et al. Among authors: chen f. Adv Sci (Weinh). 2022 Dec;9(36):e2203263. doi: 10.1002/advs.202203263. Epub 2022 Nov 7. Adv Sci (Weinh). 2022. PMID: 36344430 Free PMC article.

10

Redox Dyshomeostasis with Dual Stimuli-Activatable Dihydroartemisinin Nanoparticles to Potentiate Ferroptotic Therapy of Pancreatic Cancer.

Wang Y, Chen F, Zhou H, Huang L, Ye J, Liu X, Sheng W, Gao W, Yu H, Wang F. Wang Y, et al. Among authors: chen f. Small Methods. 2023 May;7(5):e2200888. doi: 10.1002/smtd.202200888. Epub 2022 Nov 29. Small Methods. 2023. PMID: 36446643

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26,911 results

Search Page

Filters